Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment ...

Complete Strides Pharma Science Ltd. stock information by Barron's. View real-time 532531 stock price and news, along with industry-best analysis.

Strides Acrolab scrip shot up 17.42 per cent to hit a new high of Rs 478.3 a share at BSE on Tuesday in a strong Mumbai market. At this price the company has a market cap of Rs 2,787 crore.

Indian pharmaceutical company Strides Pharma Science Ltd on Thursday received regulatory approval to start clinical trials of antiviral drug favipiravir, which has been touted as a potential ...